Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Objectively Diagnose and Monitor Treatment of Light Sensitivity

NCT: NCT03694626 · RECRUITING

NCT IDNCT03694626
StatusRECRUITING
Start Date2019-07-11
Completion2028-01-01
SponsorRandy Kardon (OTHER)
First posted
Last updated

Brief Summary

The purpose of this project is to provide a new framework for diagnosing and monitoring treatment of light sensitivity and headache by objective measurement of facial features, pupil responses, retinal electrical responses and autonomic nerve responses to light.

Frequently Asked Questions

What is Objectively Diagnose and Monitor Treatment of Light Sensitivity?

Objectively Diagnose and Monitor Treatment of Light Sensitivity is a clinical trial registered under NCT03694626. Current status: RECRUITING.

What is the status of NCT03694626?

The current status of NCT03694626 (Objectively Diagnose and Monitor Treatment of Light Sensitivity) is: RECRUITING.

When did Objectively Diagnose and Monitor Treatment of Light Sensitivity start?

Objectively Diagnose and Monitor Treatment of Light Sensitivity started on 2019-07-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.